These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38035006)

  • 1. Trofinetide-a new chapter in rett syndrome's treatment.
    Furqan M
    Front Pharmacol; 2023; 14():1284035. PubMed ID: 38035006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.
    Glaze DG; Neul JL; Kaufmann WE; Berry-Kravis E; Condon S; Stoms G; Oosterholt S; Della Pasqua O; Glass L; Jones NE; Percy AK;
    Neurology; 2019 Apr; 92(16):e1912-e1925. PubMed ID: 30918097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Peters SU; Jones NE; Youakim JM
    Contemp Clin Trials; 2022 Mar; 114():106704. PubMed ID: 35149233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the Rett Syndrome Behaviour Questionnaire and its utilization in the assessment of symptoms associated with Rett syndrome.
    Percy AK; Neul JL; Benke TA; Marsh ED; Glaze DG
    Front Pediatr; 2023; 11():1229553. PubMed ID: 37635789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trofinetide in Rett syndrome: A brief review of safety and efficacy.
    Singh A; Balasundaram MK; Gupta D
    Intractable Rare Dis Res; 2023 Nov; 12(4):262-266. PubMed ID: 38024580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need.
    Hudu SA; Elmigdadi F; Qtaitat AA; Almehmadi M; Alsaiari AA; Allahyani M; Aljuaid A; Salih M; Alghamdi A; Alrofaidi MA; Abida ; Imran M
    J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.
    Glaze DG; Neul JL; Percy A; Feyma T; Beisang A; Yaroshinsky A; Stoms G; Zuchero D; Horrigan J; Glass L; Jones NE
    Pediatr Neurol; 2017 Nov; 76():37-46. PubMed ID: 28964591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects.
    Darwish M; Nunez R; Youakim JM; Robertson P
    Clin Drug Investig; 2024 Jan; 44(1):21-33. PubMed ID: 38017349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Marsh ED; Lin T; Stankovic S; Bishop KM; Youakim JM
    Nat Med; 2023 Jun; 29(6):1468-1475. PubMed ID: 37291210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trofinetide: First Approval.
    Keam SJ
    Drugs; 2023 Jun; 83(9):819-824. PubMed ID: 37191913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial.
    Hurley EN; Ellaway CJ; Johnson AM; Truong L; Gordon R; Galettis P; Martin JH; Lawson JA
    Epilepsia; 2022 Jul; 63(7):1736-1747. PubMed ID: 35364618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of music therapy for individuals with Rett syndrome and their families.
    Chou MY; Chang NW; Chen C; Lee WT; Hsin YJ; Siu KK; Chen CJ; Wang LJ; Hung PL
    J Formos Med Assoc; 2019 Dec; 118(12):1633-1643. PubMed ID: 30670340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rett Syndrome Behaviour Questionnaire in Children and Adults With Rett Syndrome: Psychometric Characterization and Revised Factor Structure.
    Oberman LM; Leonard H; Downs J; Cianfaglione R; Stahlhut M; Larsen JL; Madden KV; Kaufmann WE
    Am J Intellect Dev Disabil; 2023 May; 128(3):237-253. PubMed ID: 37104862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of mirtazapine in adult female Mecp2
    Flores Gutiérrez J; De Felice C; Natali G; Leoncini S; Signorini C; Hayek J; Tongiorgi E
    J Neurodev Disord; 2020 Sep; 12(1):26. PubMed ID: 32988385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rett-like Phenotypes in
    Gonzalez JN; Goldman S; Carter MT; Bain JM
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trofinetide Receives FDA Approval as First Drug for Rett Syndrome.
    Harris E
    JAMA; 2023 Apr; 329(14):1142. PubMed ID: 36947078
    [No Abstract]   [Full Text] [Related]  

  • 18. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
    Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
    J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation Tools Developed for Rett Syndrome.
    Lotan M; Downs J; Stahlhut M; Romano A
    Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review.
    Tascini G; Dell'Isola GB; Mencaroni E; Di Cara G; Striano P; Verrotti A
    Front Neurol; 2022; 13():817195. PubMed ID: 35299616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.